We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abdn.Asset.Man. | LSE:ADN | London | Ordinary Share | GB0000031285 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 317.60 | 313.00 | 313.10 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
27/4/2021 14:34 | All the EEEEEEE GONE | halfpenny | |
18/1/2018 13:27 | Defunct thread. Now called Standard Life Aberdeen. Epic SLA. | lord gnome | |
18/1/2018 12:06 | What's happening with this?? | barryjoe10 | |
02/5/2017 08:08 | Positive trading update suggesting change in trend, redemptions falling and emerging markets getting net new money. | its the oxman | |
21/3/2017 12:29 | Today the Daily Mail has expressed the view that the proposed agreement in the merged companies is DOOMED as Private Fraser used to forecast. Mr Gilbert did well in his efforts getting ADN to a 500p valuation two years ago and has been rewarded handsomely financially. He obviously persuaded many of the large shareholders in ADN to go along with his ideal solution to keep his fingers in the cash box despite the share price almost halfing in value.He has ignored the possibility of selling to any other predator as he would be unlikely to be retained. His ideal solution is selfish. Time for him to go FISHING. | rabbrooks | |
06/3/2017 19:45 | Standard Life/Aberdeen: honourable surrender - ...Be under no illusion. Despite the bluster about the creation of a “world class” investment company (pro forma assets under management £660bn), this defensive deal is about stripping out costs as much as the likely scale achieved... | speedsgh | |
06/3/2017 19:12 | Now that we see the few details it is obvious that Gilbert and his senior staff will be the main beneficiaries of the merger.any other deal would be an offer to a full takeover with a higher price offered for Aberdeen shares. In this engineered merger Gilbert will retain all the benefits of his Aberdeen contract .it is doubtful if he would have been retained otherwise.millions could have been saved by the new company by saying goodbye to the golfer/fisherman.sha | rabbrooks | |
06/3/2017 15:23 | Well it gave my Shires Investment Trust a nice boost as mentioned might happen over the weekend. | essentialinvestor | |
06/3/2017 15:10 | I feel for anyone who gets into bed with Standard Life: they are not to be trusted, are dreadful administratively, try to be as obstructive as possible to financial advisers, look to poach business ... in short, a dreadful outfit. For Aberdeen to contemplate a merger with them is a sign of troubles they have and have not owned up to. Stay away from both businesses: on their own they are not good at the moment, and together it will be even worse. I say SELL SELL SELL now whilst you can can a reasonable price, or watch the drift down over time, and weep. | andrewbaker | |
06/3/2017 09:11 | Not a very good deal for ADN I think SL. are getting a cracking deal trust me to be in the wrong share. | p49b | |
06/3/2017 08:27 | Happy days, no div cut and a brighter future for all. Upgrades and details on cost cutting could yet boost us again. Fingers crossed. | its the oxman | |
06/3/2017 08:21 | Out at 307p. Always happy to take an unexpected profit and move on. May be back once the dust has settled. | lord gnome | |
06/3/2017 08:07 | Up 7.5%. SL up 9.5% | dr biotech | |
06/3/2017 08:06 | Can anyone see what the share is doing? | joshgroeny | |
06/3/2017 07:29 | What a bad deal for ADN shareholder,s not even a premium to Friday,s close of 286. | garycook | |
05/3/2017 21:05 | StanLife aims to pull off masterstroke amid rise of passive rivals 2 Articles in the financial times | ferries5 | |
05/3/2017 16:40 | Gilbert looked dreadful and in his cups while being interviewed in Davos on TV with a.richards.he has lost his mojo as they say.hopefully some of the other big players will will take an interest in adn. | rabbrooks | |
05/3/2017 14:50 | Or Blackrock.... | f1araway | |
05/3/2017 14:11 | In which case, ganthorpe, we should indeed see an uplift in the ADN share price in the morning. This proposed merger could just be a defensive move by ADN. As other posters have said, this may indeed smoke out other more-hostile interests, including possibly HSBC. | lord gnome | |
05/3/2017 12:05 | Don't know how SL is only twice the market cap of ADN. SL is £9100M and ADN £3774M which is 74%/26% by my reckoning. On the basis of 2/3 SL and 1/3ADN we should be buying ADN and selling SL? Besides which ADN's divi looks vulnerable ans SL in the stronger position. I hold SL but gave up on ADN a year ago - so I'm biased. | ganthorpe | |
05/3/2017 10:16 | Will some of the Aberdeen funds get a mini lift tomorrow?, hold Shires Income Trust which pays out a lovely quarterly income, still yielding over 5% atm. | essentialinvestor | |
05/3/2017 10:04 | If its going to be a merger rather than a takeover - and all the wording has indicated its the former then there would be no increased offer. It looks sensible - SL is twice the market cap of ADN and therefore they get 66% of the combined group. So it theory the SPs of the individual co's should be locked to each other. SL makes up about 6% of my total holding and is the largest individual share that I have so not insignificant for me. I have never held here, but given the both BBs are quiet I look forward to the merger of those :-) | dr biotech | |
05/3/2017 08:27 | I did speculate the chances of a takeover last week. Since this is the opening savo, I expect other interested buyers to throw their hats in. Forget about 0.757 if SL shares. This will rocket to 330 - 350p as a fair value on Monday | heo | |
05/3/2017 00:05 | No premium to ADN price re .75 of SL. on Fridays close. | p49b |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions